Currently, maternal consultation on ECV success is limited to quoted success rates, varying from 35-83% in different studies.
Oxytocin regimen for induction of labor and pregnancy outcomes
Uma Reddy for the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, Bethesda, MD OBJECTIVE: Uncertainty exists regarding the optimal oxytocin dose regimen for induction of labor (IOL). We evaluated the association of oxytocin regimen for IOL with cesarean delivery and with adverse perinatal composite outcome in low-risk nulliparous women. STUDY DESIGN: Secondary analysis of a multi-center randomized control trial of IOL at 39 weeks compared with expectant management in low-risk nulliparous women. Women in either group who underwent IOL with a mid-to high-dose oxytocin (MHD) regimen were compared with those induced with a low-dose oxytocin (LD) regimen. The primary outcomes were cesarean delivery and a composite of perinatal death or severe neonatal complications (Table  1) . M ultivariable regression was used to estimate relative risks (RR) controlling for related covariates, although site could not be adjusted for given collinearity with oxytocin regimen. Interaction between oxytocin regimen and modified Bishop score, induction indication and treatment group were also evaluated. RESULTS: Of 6,106 women enrolled in the primary trial, 3,034 women underwent induction with oxytocin; 889 in the MHD group and 2145 in the LD group. There was a shorter duration from start of oxytocin to delivery (median 11.7 hours vs. 13.4 hours) and higher percentage of women in the lowest quartile for time to delivery in ajog.org
Poster Session IV
Supplement to JANUARY 2019 American Journal of Obstetrics & Gynecology S529
the MHD group compared with the LD group (p<0.001 for both). The lower frequency of cesarean delivery in the MHD group (20.9% vs. 25.0%) was not significant after adjustment (Table 1) . There was an increase in operative vaginal delivery in the MHD group (9.7% vs. 6.8%, P¼0.007). The adverse perinatal composite outcome was significantly more frequent in the MHD group (6.6% vs. 4.3%, adjusted RR 1.59, 95% CI (1.15-2.21)) compared with LD group; this association was most notable among those with an elective induction (p¼0.03 for interaction). The higher frequency of the adverse perinatal outcome in the MHD group was mostly due to a higher frequency of continuous positive airway pressure or high-flow nasal cannula (Table 2) . CONCLUSION: Compared with LD regimen, MHD regimen for induction was associated with a similar chance of spontaneous vaginal delivery as well as a higher risk of an adverse perinatal composite outcome, particularly for elective induction. It remains uncertain if this finding is related to the actual regimen or other confounding variables such as site of use. OBJECTIVE: Evidence in support of longer trials of labor has altered labor management significantly since the development of the Maternal Fetal Medicine Units Network (MFMU) vaginal birth after cesarean (VBAC) success prediction model. We aimed to assess the validity of this model in a high-risk center employing contemporary labor management standards. STUDY DESIGN: This is a retrospective cohort study of all women with non-anomalous singleton gestations 37 weeks and one prior low transverse cesarean who attempted a trial of labor after cesarean (TOLAC) at our academic tertiary care center between January 2011 and May 2018. MFMU antenatal VBAC prediction model variables were extracted from medical records and used to calculate chance of success. Predicted VBAC success rates were grouped into deciles and compared to observed success rates within each decile. RESULTS: Of 1307 VBAC attempts, 1042 pregnancies met inclusion criteria with variables necessary for calculation of predicted VBAC success. As anticipated, most of the variables included in the antenatal MFMU model differed between women who had a successful TOLAC and those who did not (Table 2) . While a similar percentage of them had chronic hypertension or developed gestational hypertension, mild preeclampsia, or gestational diabetes, fewer women who had a successful TOLAC had pregestational diabetes and fewer developed severe preeclampsia. The median predicted VBAC success rate was 71.5 % (IQR 52.6, 85.4) while the observed success rate was 74.2 % (difference 2.7 %, 95% CI -1.1-6.5 %). The median predicted probability of success was significantly higher for women who had a successful TOLAC (median 72.7 % (IQR 57.8, 84.9) than for those who had a repeat cesarean (57.5 % (IQR 38.6, 72.) . Receiver operating characteristic curve for this model yielded an area under the curve (AUC) of 0.69 (95% CI 0.65 e 0.72), indicating relatively poor performance. While there was no significant difference between predicted and observed VBAC rates when the predicted rate was <30% and >60%, the success rate was significantly higher than expected for those women with a predicted rate of 31-60% (P < .05). The uterine rupture rate was 1.2%, which was similar to previously reported rates. CONCLUSION: The MFMU VBAC calculator performance was suboptimal in this cohort of women undergoing TOLAC in the contemporary labor management era. The model may underestimate the rate of success, particularly for women with a moderate to low predicted success rate.
